(1) Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M.Hepatology.
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
(2) Xuyun He, Guang Ji, Wei Jia, and Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of http://Metabolomics.Int J Mol Sci. 2016 Mar; 17(3): 300.Published online 2016 Mar 15. doi: 10.3390/ijms1703030.
(3) Bashiardes S, Shapiro H, Rozin S, Shibolet O, Elinav E. Non-alcoholic fatty liver and the gut microbiota. Mol Metab. 2016 Jun 14;5(9):782-94. doi: 10.1016/j.molmet.2016.06.003. eCollection 2016 Sep.
(4) Kim D1, Kim WR2.Nonobese Fatty Liver Disease.Clin Gastroenterol Hepatol. 2017 Apr;15(4):474-485. doi: 10.1016/j.cgh.2016.08.028. Epub 2016 Aug 28.
(6) Thin NAFLD Patients Have High Death Risk, by Charles Bankhead, Staff Writer, MedPage Today, May 5, 2014
(7) Hallsworth K, Thoma C, Hollingsworth KG, Cassidy S, Anstee QM, Day CP, Trenell MI. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. Clin Sci (Lond). 2015 Dec;129(12):1097-105. doi: 10.1042/CS20150308. Epub 2015 Aug 11.
(8) Nigam P, Bhatt S, Misra A, Chadha DS, Vaidya M, Dasgupta J, Pasha QM. Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male Asian Indians with nonalcoholic fatty liver disease. Diabetes Technol Ther. 2014 Apr;16(4):255-61. doi: 10.1089/dia.2013.0178.
(9) Sakata R, Nakamura T, Torimura T, Ueno T, Sata M. Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study. Int J Mol Med. 2013 Nov;32(5):989-94. doi: 10.3892/ijmm.2013.1503. Epub 2013 Sep 20.
(10) Rocha R, Cotrim HP, Siqueira AC, Floriano S. Non alcoholic fatty liver disease: treatment with soluble fibres. Arq Gastroenterol. 2007 Oct-Dec;44(4):350-2.